Targeting ESM1 via SOX4 promotes the progression of infantile hemangioma through the PI3K/AKT signaling pathway
SOX4 plays a crucial role in the progression of IH, and the SOX4/ESM1 axis may serve as a novel biomarker and potential therapeutic target for IH.
Authors
- Tong Qiu (ORCID: https://orcid.org/0000-0001-6188-1030)
- Yi Ji (ORCID: https://orcid.org/0000-0002-9289-9660)
- Meng Kong (ORCID: https://orcid.org/0000-0002-7879-8839)
- Yanan Li (ORCID: https://orcid.org/0000-0003-4396-0557)
Institutions
- Shandong University (CN)
- Sichuan University (CN)
Publication Details
- Journal
- Precision Clinical Medicine
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1093/pcmedi/pbae026
- Citations
- 5
- Primary Topic
- Inflammation biomarkers and pathways
- Type
- article
- Field-Weighted Citation Impact
- 1.20
Funders
- National Natural Science Foundation of China
- Sichuan University
- Natural Science Foundation of Shandong Province
- West China Hospital, Sichuan University